drug summary · 22 NDC codes
Optiray 350 741 mg/mL
Ioversol
HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status NDA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.
Facts
Field definitions, types, and provenance rules are in the data dictionary.
| generic name | Ioversol |
|---|---|
| active ingredients | IOVERSOL |
| dosage form | INJECTION |
| route | INTRA-ARTERIAL, INTRAVENOUS |
| strength | 741 mg/mL |
| marketing status | NDA |
| DEA schedule | not reported |
| application number | NDA020923 |
| ATC code | not reported |
| RxCUI | not reported |
| manufacturer | Liebel-Flarsheim Company LLC |
| product type | HUMAN PRESCRIPTION DRUG |
| pharmacologic class | Radiographic Contrast Agent [EPC]; X-Ray Contrast Activity [MoA] |
NDC codes
22 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.
| NDC | Package description |
|---|---|
| 00019133300 | — |
| 00019133306 | — |
| 00019133311 | — |
| 00019133316 | — |
| 00019133321 | — |
| 00019133327 | — |
| 00019133351 | — |
| 00019133352 | — |
| 00019133355 | — |
| 00019133361 | — |
| 00019133365 | — |
| 00019133375 | — |
| 00019133377 | — |
| 00019133378 | — |
| 00019133381 | — |
| 00019133383 | — |
| 00019133385 | — |
| 00019133387 | — |
| 00019133390 | — |
| 00019133391 | — |
| 00019133395 | — |
| 0019-1333 | — |
Other Ioversol products
One other product in the current release publishes the same generic name. Strength, dosage form, and labeler are what distinguish them.
- Optiray 320 678 mg/mLINJECTION · Liebel-Flarsheim Company LLC
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access to the full catalogue; credited toward the licence.